| The neurofibromatosis 2 tumor suppressor protein interacts with hepatocyte growth factor-regulated tyrosine kinase substrate DR Scoles, DP Huynh, MS Chen, SP Burke, DH Gutmann, SM Pulst Human molecular genetics 9 (11), 1567-1574, 2000 | 95 | 2000 |
| Heterozygosity for the tuberous sclerosis complex (TSC) gene products results in increased astrocyte numbers and decreased p27-Kip1 expression in TSC2+/− cells EJ Uhlmann, AJ Apicelli, RL Baldwin, SP Burke, ML Bajenaru, H Onda, ... Oncogene 21 (25), 4050-4059, 2002 | 93 | 2002 |
| The NF2 interactor, hepatocyte growth factor-regulated tyrosine kinase substrate (HRS), associates with merlin in the ‘open’ conformation and suppresses cell … DH Gutmann, CA Haipek, SP Burke, CX Sun, DR Scoles, SM Pulst Human molecular genetics 10 (8), 825-834, 2001 | 68 | 2001 |
| cIAP1 cooperatively inhibits procaspase-3 activation by the caspase-9 apoptosome SP Burke, L Smith, JB Smith Journal of biological chemistry 285 (39), 30061-30068, 2010 | 41 | 2010 |
| Both HIV-infected and uninfected cells express TRAILshort, which confers TRAIL resistance upon bystander cells within the microenvironment Z Nie, F Aboulnasr, S Natesampillai, SP Burke, A Krogman, GD Bren, ... The Journal of Immunology 200 (3), 1110-1123, 2018 | 16 | 2018 |
| Monomerization of cytosolic mature smac attenuates interaction with IAPs and potentiation of caspase activation SP Burke, JB Smith PLoS One 5 (10), e13094, 2010 | 15 | 2010 |
| The 43,000 growth-associated protein functions as a negative growth regulator in glioma Z Huang, YL Wu, SP Burke, DH Gutmann Cancer research 63 (11), 2933-2939, 2003 | 13 | 2003 |
| A dose-escalating toxicology study of the candidate biologic ELP-VEGF JP Waller, SP Burke, J Engel, AR Chade, GL Bidwell III Scientific Reports 11 (1), 6216, 2021 | 9 | 2021 |
| Elastin-like polypeptide delivery of anti-inflammatory peptides to the brain following ischemic stroke JA Howell, N Gaouette, M Lopez, SP Burke, E Perkins, GL Bidwell III bioRxiv, 2023 | 3 | 2023 |
| DETERMINING THE EFFECTS OF PRO‐ANGIOGENIC ELP‐VEGF THERAPY ON TUMOR GROWTH AND PROGRESSION J Waller, S Burke, J Engel, A Chade, G Bidwell The FASEB Journal 34 (S1), 1-1, 2020 | 1 | 2020 |
| Biodistribution and Efficacy of an NF‐κB‐Targeted Biologic for Therapy of Ischemic Stroke JA Howell, E Perkins, S Burke, M Lopez, GL Bidwell III The FASEB Journal 36, 2022 | | 2022 |
| Proximal Tubule Epithelial Cell Reabsorption of the Drug Delivery Protein Elastin‐like Polypeptide AA Akinleye, S Burke, GL Bidwell The FASEB Journal 34 (S1), 1-1, 2020 | | 2020 |
| A Biopolymer‐Fused Form of VEGF‐B for Treatment of Preeclampsia JP Waller, SP Burke, OC Logue, GL Bidwell The FASEB Journal 33 (S1), 865.7-865.7, 2019 | | 2019 |
| Both HIV-infected and uninfected cells express TRAILshort, which confers TRAIL resistance upon bystander cells within the microenvironment (vol 200, pg 1110, 2018) Z Nie, F Aboulnasr, S Natesampillai, SP Burke, A Krogman, GD Bren, ... JOURNAL OF IMMUNOLOGY 201 (5), 1599-1599, 2018 | | 2018 |
| Daily Subcutaneous Administration of a Biopolymer-Stabilized VEGF Chimera Optimizes Therapeutic Efficacy in Treating a Rodent Model of Placental Ischemia. OC Logue, SP Burke, EM George, GL Bidwell HYPERTENSION 72, 2018 | | 2018 |
| Abstract P182: Daily Subcutaneous Administration of a Biopolymer-Stabilized VEGF Chimera Optimizes Therapeutic Efficacy in Treating a Rodent Model of Placental Ischemia OC Logue, SP Burke, EM George, GL Bidwell Hypertension 72 (Suppl_1), AP182-AP182, 2018 | | 2018 |
| NC 100150 EJ Uhlmann, AJ Apicelli, RL Baldwin, SP Burke, ML Bajenaru, H Onda, ... Drugs in R and D 3 (5), 303-304, 2002 | | 2002 |
